Abstract

Clopidogrel 5 mg/mL in a Sugar-Free Syrup

Author(s): Allen Loyd V Jr

Issue: May/Jun 2019 - Volume 23, Number 3

Page(s): 232

Download in electronic PDF format for $75
  • Clopidogrel 5 mg/mL in a Sugar-Free Syrup Page 1

Abstract

A formulation for preparing Clopidogrel 5 mg/mL in a Sugar-Free Syrup. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • clopidogrel
  • platelet inhibitor
  • acute coronary syndromes
  • anticoagulant
  • blood clotting disorders

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2019
Pg. 232
Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 435-437
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
Mar/Apr 2011
Pg. 158
Clopidogrel 5-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 58
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59
Suspension Solution, Sugar Free
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2004
Pg. 458-460
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
Author(s): McElhiney Linda F
Jan/Feb 2002
Pg. 17
Fluoride 0.25-mg Sugar-Free Hard Candy
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
Jan/Feb 2001
Pg. 65-67
Oral Liquid Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 296
Sugar-Free Suspension Structured Vehicle, USP
Author(s): Allen Loyd V Jr
Mar/Apr 2000
Pg. 136
Sugar-Free Suspension Structured Vehicle, USP
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2015
Pg. 252-260
Protocol of Blood Serum Eye Drops
Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr